Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bate

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Drug Safety|December 6, 2011
Terminological challenges in safety surveillanceAndrew Bate, Elliot G Brown, Stephen A Goldman, et al.
JAMIA Open|February 10, 2025
Automating pharmacovigilance evidence generation: using large language models to produce context-aware structured query languageJeffery L Painter, Venkateswara Rao Chalamalasetti, Raymond Kassekert, et al.
Pharmacoepidemiology and Drug Safety|June 4, 2011
Safety surveillance of longitudinal databases: methodological considerationsG Niklas Norén, Johan Hopstadius, Andrew Bate, et al.
Statistics in Medicine|December 29, 2005
Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare eventsG Niklas Norén, Andrew Bate, Roland Orre, et al.
Drug Safety|February 22, 2011
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBaseJohanna Strandell, Ola Caster, Andrew Bate, et al.
Drug Discovery Today|December 24, 2015
Designing and incorporating a real world data approach to international drug development and use: what the UK offersAndrew Bate, Jane Juniper, Andy M Lawton, et al.
Drug Safety|June 10, 2023
Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated DataFahed Al-Azzawi, Israa Mahmoud, François Haguinet, et al.
The Journal of Clinical Psychiatry|February 10, 2010
Sudden cardiac death in users of second-generation antipsychoticsJohn Karlsson, Susanna M Wallerstedt, Kristina Star, et al.
Pharmacoepidemiology and Drug Safety|October 11, 2022
Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic reviewAstrid Coste, Angel Wong, Marleen Bokern, et al.
Journal of Biopharmaceutical Statistics|November 22, 2017
Assessing performance of sequential analysis methods for active drug safety surveillance using observational dataXiaofeng Zhou, Warren Bao, Mike Gaffney, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Drug Safety|December 6, 2011
Terminological challenges in safety surveillanceAndrew Bate, Elliot G Brown, Stephen A Goldman, et al.
JAMIA Open|February 10, 2025
Automating pharmacovigilance evidence generation: using large language models to produce context-aware structured query languageJeffery L Painter, Venkateswara Rao Chalamalasetti, Raymond Kassekert, et al.
Pharmacoepidemiology and Drug Safety|June 4, 2011
Safety surveillance of longitudinal databases: methodological considerationsG Niklas Norén, Johan Hopstadius, Andrew Bate, et al.
Statistics in Medicine|December 29, 2005
Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare eventsG Niklas Norén, Andrew Bate, Roland Orre, et al.
Drug Safety|February 22, 2011
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBaseJohanna Strandell, Ola Caster, Andrew Bate, et al.
Drug Discovery Today|December 24, 2015
Designing and incorporating a real world data approach to international drug development and use: what the UK offersAndrew Bate, Jane Juniper, Andy M Lawton, et al.
Drug Safety|June 10, 2023
Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated DataFahed Al-Azzawi, Israa Mahmoud, François Haguinet, et al.
The Journal of Clinical Psychiatry|February 10, 2010
Sudden cardiac death in users of second-generation antipsychoticsJohn Karlsson, Susanna M Wallerstedt, Kristina Star, et al.
Pharmacoepidemiology and Drug Safety|October 11, 2022
Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic reviewAstrid Coste, Angel Wong, Marleen Bokern, et al.
Journal of Biopharmaceutical Statistics|November 22, 2017
Assessing performance of sequential analysis methods for active drug safety surveillance using observational dataXiaofeng Zhou, Warren Bao, Mike Gaffney, et al.
Pageof 11